Request for Sample
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
Global Nanoparticles Market Overview :
“The global Nanoparticles Market size is expected to be worth around US$ xx Billion by 2021 from US$ X.xx million in 2031, growing at a CAGR of X.x% during the forecast period 2021 to 2031.”
The report offers insightful and detailed information regarding the various key players operating in the global nanoparticles market, their financials, supply chain trends, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global nanoparticles market report has been segmented on the basis of technology, end use, and region.
Nanoparticles are tiny materials having size ranges from 1 to 100nm and possess unique physical and chemical properties due to its very high surface area to volume ratio. Nanoparticle have numerous clinical applications, such as chemotherapy drug attached to nanodiamonds are being tested for brain tumor treatment. Furthermore, use of polymer coated iron oxide nanoparticles to break up cluster of bacteria allows more effective treatment of chronic bacterial infections. Nanoparticles are particularly used for drug delivery in cancer and inflammatory disease therapies. Nanoparticle based technology provides an opportunity for improving the efficacy of the treatment.
Increasing drug development in pharmaceutical industry for treating disease using nanotechnology is expected to drive the growth of nanoparticles market over the forecast period. Moreover, rising collaboration between private organization and government focusing on continuous advancements in nanoparticles technologies is anticipated to further drive the growth of the global nanoparticles market over the forecast period.
Nanoparticle are sensitive to manufacturer and ensuring consistent particle characteristics at different scales of production are major factors restraining growth of the global nanoparticles market.
However, technological advancements and innovations focusing on use of nanotechnology in drug development and drug delivery processes for diagnosis and treatment purpose is expected to create new opportunities for major players in the global nanoparticles market over the forecast period.
North America market dominates the global nanoparticles market in terms of revenue contribution as compared to that of markets in other regions. This is attributed to increasing chronic diseases such as diabetes, cardiovascular and cancer in the region. Europe accounts for second-largest revenue share contribution to the global nanoparticles market, followed by markets in Latin America, Asia Pacific, and Middle East & Africa respectively. The market in Asia Pacific is projected to register comparatively faster growth in terms of revenue over the next 10 years, owing to increasing government spending in pharmaceutical R&D in the region.
Global Nanoparticles Market Segmentation:
Global nanoparticles market segmentation, by technology:
- Polymeric nanoparticles
- Polymer conjugated drugs
- Inorganic nanoparticles
Global nanoparticles market segmentation, by end use:
- Pharmaceuticals industry
- Biochemical industry
- Research institutions
Global nanoparticles market segmentation, by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- Abraxis Biosciences, Inc.
- Novartis AG
- Gilead Sciences
- Johnson & Johnson
- Amgen, Inc.
- Nano Interface Technology, Inc.
- Wyatt Technology Corporation
- Bruker Corporation
- Malvern Instruments Ltd.
- Agilent Technologies, Inc.
Request for TOC
Don't just take our word. We are trusted by these great companies!